Alkamides and Piperamides as Potential Antivirals against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Gutierrez-Villagomez, Juan Manuel; Campos-García, Tonatiu; Molina-Torres, Jorge; López, Mercedes G. et Vázquez-Martínez, Juan (2020). Alkamides and Piperamides as Potential Antivirals against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The Journal of Physical Chemistry Letters . pp. 8008-8016. DOI: 10.1021/acs.jpclett.0c01685.

Prévisualisation

PDF Télécharger (884kB) | Prévisualisation

Résumé

The pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has quickly spread globally, infecting millions and killing hundreds of thousands of people. Herein, to identify potential antiviral agents, 97 natural amide-like compounds known as alkamides and piperamides were tested against SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp), and the human angiotensin-converting enzyme 2 (ACE2) using molecular docking and molecular dynamics simulations. The docking results showed that alkamides and dimeric piperamides from Piper species have a high binding affinity and potential antiviral activity against SARS-CoV-2. The absorption, distribution, metabolism, and excretion (ADME) profile and Lipinski’s rule of five showed that dimeric piperamides have druglikeness potential. The molecular dynamics results showed that pipercyclobutanamide B forms a complex with Mpro at a similar level of stability than N3-I. Our overall results indicate that alkamides and piperamides, and specifically pipercyclobutanamide B, should be further studied as compounds with SARS-CoV-2 antiviral properties.

Type de document:	Article
Mots-clés libres:	covid19; coronavirus;
Centre:	Centre Eau Terre Environnement
Date de dépôt:	25 sept. 2020 21:12
Dernière modification:	26 août 2021 04:00
URI:	https://espace.inrs.ca/id/eprint/10386

Gestion Actions (Identification requise)

Modifier la notice